US Pharma MarketingFDA search for new CBER head focused on small group of final candidates
The FDA has narrowed its search for a new leader of its Center for Biologics Evaluation and Research to three to four final candidates, Endpoints News has learned. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act…
The FDA has narrowed its search for a new leader of its Center for Biologics Evaluation and Research to three or four final candidates, according to a person familiar with the matter.
The agency hopes ...
Source: Endpoints News